Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial

By Verheugt Freek   Montalescot Gilles   Sabatine Marc   Soulat Louis   Lambert Yves   Lapostolle Frédéric   Adgey Jennifer   Cannon Christopher  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 3, 2007-06 ,pp. : 173-179

Springer Publishing Company

Access to resources Recommend Favorite

Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis

By Ahmed Shaheeda  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 493-500

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction

By Andersen H.R.   Nielsen T.T.   Rasmussen K.   for the DANAMI-2 Investigators  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 47-47

Elsevier

Access to resources Recommend Favorite

Aspirin, beta-blocker and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

By Berger A.K.   Duval S.   Krumholz H.M.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 17-17

Elsevier

Access to resources Recommend Favorite

Soluble thrombomodulin antigen in plasma is increased in patients with acute myocardial infarction treated with thrombolytic therapy

By Ohlin A.-K.   Morser J.   Ohlin H.  

Thrombosis Research, Vol. 82, Iss. 4, 1996-05 ,pp. : 313-322

Elsevier

Access to resources Recommend Favorite